US008232265B2 (12) United States Patent (10) Patent No.: US 8,232,265 B2 Rogers et al. (45) Date of Patent: Jul. 31, 2012 (54) MULTI-FUNCTIONAL IONIC LIQUID 25. A 8. 3. MadeuZZi et al. ..... : COMPOSITIONS FOR OVERCOMING 4,491,574 A 1/1985 Seifter et al. .................... 424/10 POLYMORPHISMAND IMPARTING 4,761,164 A 8, 1988 Pez et al. .......................... 55/16 IMPROVED PROPERTIES FORACTIVE 4,973,456 A 1 1/1990 Quinn et al. 423,210.5 PHARMACEUTICAL, BIOLOGICAL, 539W - I A s 3: E.OCSC heralCal. ............. $2. NUTRITIONAL AND ENERGETIC 5,679,146 A 10/1997 Kalt et al. .......... ... 106,166.01 INGREDIENTS 5,683,832 A 1 1/1997 Bonhote et al. ............... 429,111 5,731, 101 A 3, 1998 Sherifet al. ....... ... 429,102 (75) Inventors: Robin D. Rogers, Tuscaloosa, AL (US); 5,792,399 A 8, 1998 Meister et al. ... 264/101 Daniel T. Daly, Tuscaloosa, AL (US); 5,827,602 A 10, 1998 Koch et al. ..... ... 429,194 Richard P. Swatloski, Tuscaloosa, AL 993,--- f $3. E.urgard et al......................... .. 428/402.2 556,119 (US); Whitney L. Hough, Albertville, 6,774,240 B2 8/2004 Seddon et al. ..... ... 548/347.1 AL (US); James Hilliard Davis, Jr., 6,808,557 B2 10/2004 Holbrey et al. .......... 106,163.01 Mobile, AL (US); Marcin Smiglak, 6,824,599 B2 11/2004 Swatloski et al. ....... 106,163.01 6,846,926 B1 1/2005 Koppes et al. ................ 544,198 oznanCNE (PL); Scottork K. Spear,St. EasSLOn, 6,924.3416,906,004 B2 * 8/20056/2005 MaysParrish et et al. al. ....................... 504,127526,89 AL (US) 6,939,882 B1 9/2005 Cooke et al. ... ... 514,336 6,939,974 B2 9/2005 Earle et al. .. 548/347.1 (73) Assignee: Board of Trustees of the University of 7,166,641 B2 * 1/2007 Lee et al. ... ... 514,561 Alabama, Tuscaloosa, AL (US) 2002/0010291 A1 1/2002 Murphy ............. 526,133 s s 2002/0161261 A1 10, 2002 Bahrmann et all 564,281 - 2003, OO73604 A1 4, 2003 McGolfetal. 510,441 (*) Notice: Subject to any disclaimer, the term of this 2004.0007693 A1 1/2004 Moulton ........ ... 252/.364 patent is extended or adjusted under 35 2004/0026.666 A1 2/2004 Chauvin et al. ............... 252/364 U.S.C. 154(b) by 1208 days. 2004/0146549 A1 7/2004 Ben-Sasson et al. ......... 424/449 2004/0234966 Al 11/2004 Bryning et al. ................... 435/6 (21) Appl No.: 11A545,938 2005/OO587O2 A1 3/2005 Ben-Sasson et al. ......... 424/452 y x- - - 9 2005/0136103 A1 6/2005 Ben-Sasson et al. ......... 424/449 (22) Filed: Oct. 10, 2006 (Continued) (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2007/0093462 A1 Apr. 26, 2007 CA 2619367 A1 T 2009 (Continued) Related U.S. Application Data (60) Provisional application No. 60/764,850, filed on Feb. OTHER PUBLICATIONS 2, 2006, provisional application No. 60/724,604, filed Avent et al., “Evidence for hydrogen bonding in solutions of 1-Ethyl on Oct. 7, 2005, provisional application No. 3-imidazolium Halides, and its implications for ambient temperature 60/724,605, filed on Oct. 7, 2005. Halogenoaluminate(III) ionic liquids.” J. Chem. Soc., Dalton Trans., 3405 (1994). (51) Int. Cl. Bates et al., "CO2 capture by a task-specific ionic liquid.” J. Am. A6 IK3I/33 (2006.01) Chem. Soc. 124(6): 926-927 (2002). A6 IK3I/445 (2006.01) Bernstein, “Polymorphism of high energy materials.” Polymorphism A6 IK3I/21 (2006.01) in Molecular Crystals, 275-296 (2002). A6 IK3I/24 (2006.01) Bernstein, “Introduction and historical background.” Polymorphism A6 IK3I/6 (2006.01) in Molecular Crystals, 1-28 (2002). AOIN 43/90 (2006.01) Bernstein, “Crystal structure prediction and polymorphism.” ACA AOIN 37/30 (2006.01) Transactions, 39:14-23 (2004). AOIN37/18 (2006.01) (52) U.S. Cl. ........ 514/183; 514/306; 514/330; 514/513; (Continued) 514/535; 514/555 Primary Examiner — Alton Pryor (58) Fieldee application t state file for completeSeash - -search - - - - - - - -hhi history. - - - - - - - - None &(74) Curfman, Attorney, LLC Agent, or Firm — McKeon, Meunier, Carlin (56) References Cited (57) ABSTRACT U.S. PATENT DOCUMENTS Disclosed are ionic liquids and methods of preparing ionic 1943,176 A 1/1934 Graenacher ................... 260/100 liquid compositions of active pharmaceutical, biological, 2,004,891 A * 6/1935 Goldberg ...................... 514,533 nutritional, and energetic ingredients. Also disclosed are 3,223,704 A 12, 1965 Shibe ... ... 260,247.1 methods of using the compositions described herein to over 3. As A 3. E. St. .364;2. come polymorphism, overcome solubility and delivery prob 3.47 1423 A 10, 1969 Elmer ....... ... 260/22 lems, to control release rates, add functionality, enhance effi 4,104,368 A 8, 1978 Lala et al. 424,60 cacy (synergy), and improve ease of use and manufacture. 4,171,352 A * 10/1979 Wolgemuth et al. ... 436/86 4,188,263. A 2, 1980 Hulsmann et al. ............ 439/179 9 Claims, 6 Drawing Sheets US 8,232,265 B2 Page 2 U.S. PATENT DOCUMENTS Cuppen et al., “Crystal structure and growth behavior of aspartame 2005, 0194561 A1 9/2005 Davis .............................. 252/67 form I-A.” Crystal Growth & Design, 5(3) 917-923 (2005). 2005/0232981 A1 10, 2005 Ben-Sasson .................. 424/448 Davis et al., “Thiazolium-ion based organic ionic liquids (OILS). 2006, O159632 A1 7/2006 Ishibashi et al. Novel OILs which promote the benzoin condensation.” Tetrahedron 2007/0053939 A1 3/2007 Yokoyama et al. Lett. 40: 1621-1622 (1999). 2007/0054952 A1 3/2007 Hamamoto et al. Davis et al., From curiosities to commodities: Ionic liquids begin the 2009,0264664 A1 10, 2009 Endo et al. 2010, 0004608 A1 1/2010 Hamamoto et al. transformation, Chem. Comm. 1209-1211 (2003). 2010.00297.04 A1 2/2010 Hanma et al. Domagk, "A new class of disinfectants.” Deut. Med. Wochenschr. 61:829 (1935). FOREIGN PATENT DOCUMENTS Dupont et al., “Room temperature molten salts: Neuteric "Green” DE 93-43O8410 3, 1993 Solvents for chemical reactions and processes.” Braz. Chem. Soc. EP 1405646 * 4, 2004 11(4):337-344 (2000). ES 8406412 4f1983 Elaiwi et al., “Hydrogen bonding in Imidazolium salts and its impli FR 1404697 5, 1965 cations for ambient-termperature Halogenoaluminate (III) ionic liq GB 869149 5, 1961 GB 1067094 5, 1964 uids.” Chem. Soc., Dalton Trans., 3467 (1995). GB 1473.603 5, 1971 Fanninet al., “Properties of 1,3-Dialkylimidazolium chloride-alumi JP 61-236818 10, 1986 num chloride ionic liquids. 2. Phase transitions, densities, electrical JP 62-198609 9, 1987 conductivities, and viscosities,” J. Phys. Chem... 88:2614-2621 JP 63-0565O1 3, 1988 (1984). JP 2005-82512 3, 2005 Fraga-Dubreuil et al., “Grafted ionic liquid-phase-supported synthe JP 2005 082512 3, 2005 sis of Small organic molecules.” Tetrahedron Lett. 42:6097-6100 JP 2005082512. A 3, 2005 NL 3O2478 10, 1965 (2001). WO WO95/21806 8, 1995 Freemantle, "Ionic liquids show promise for clean separation tech WO WO95/21871 8, 1995 nology.” Chem. Eng. News, 76(34):34 (1998). WO WO95/21872 8, 1995 Freemantle, “Eyes on ionic liquids.” Chem. Eng. News, 78(2):37-50 WO WO 97/43012 11, 1997 (2000). WO WO 98.51283 11, 1998 Fukumoto et al., “Room temperature ionic liquids from 20 natural WO WO98.51283 A1 11, 1998 amino acids.” J. Am. Chem. Soc. 2398-2399 (2005). WO WOO3,O29329 4/2003 WO WO 2004/O75877 9, 2004 Geppi et al., “Molecular properties of ibuprofen and its solid disper WO WO 96.06593 3, 2006 sions with eudragit RL100 studied by Solid-state nuclear magnetic WO WO 2009/060629 A1 5, 2009 resonance.” Pharm. Res., 22(9) 1544-1555 (2005). WO WO 2009,066457 A1 5/2009 Gordon et al., "Fused organic salts. 8. Properties of molten straight WO WO 2009,075094 A1 6, 2009 chain isomers of tetra-N-pentylammonium salts.” J. Amer: Chem. WO WO 2009,119836 A1 10/2009 Soc. 100(24):7445-7454 (1978). Hamaguchi et al., “Structure of ionic liquids and ionic compounds: OTHER PUBLICATIONS Are ionic liquids genuine liquids in the conventional sense.” Bhatt et al., “Saccharin as a salt former. Enhanced solubilities of Advances in Chem. Physics, 131:85-104 (2005). Saccharinates of active pharmaceutical ingredients.” Chem. Comm., Hartman et al., "Acid soaps,” J. Applied Chem., 41: 127 (1928). 1073-1075 (2005). Haynes et al., “Occurrence of pharmaceutically acceptable anions Black et al., “Increased chemical purity using a hydrate.” Crystal and cations in the Cambridge structural database.” J. Pharm. Sci., Growth & Design, 4(3) 539-544 (2004). 94(10) 2111-2120 (2005). Bonhote et al., “Hydrophobic, highly conductive ambient Holbrey et al., “Ionic liquids.” Clean Products and Processes 1:223 termperature molten salts.” Inorg. Chem. 35:1168-1178 (1996). 236 (1999). Bowlas et al., “Liquid crystalline ionic liquids.” Chem. Comm. 1625 Holbrey et al., “The phase behaviour of 1-alkyl-3-methlimidazolium (1996). tetrafluoroborates; Ionic liquids and ionic liquid crystals. J. Chem. Browning et al., “Relationships between antiseptic action and chemi Soc. Dalton Trans., 2133-2139 (1999). cal constitution with special reference to compounds of the pyridine, Huddleston et al., “Characterization and comparison of hydrophilic quinoline, acridine and phenazine seriers.” Proc. Royal Soc. London, and hydrophobic room temperature ionic liquids incorporating the 93(653):329-366 (1922). imidazolium cation.” Green Chem., 3:156-164 (2001). Browning et al., “The antiseptic properties of the amino derivatives of International Search Report and Written Opinion of the International styryl and anil quinoline.” Proc. Royal Soc. London, 100(703):293 Searching Authority for PCT/US06/39454. 325 (1926). Jacobs et al., “On a new group of bactericidal Substances obtained Butcher et al., “Initial screening trials of some quaternary ammonium from hexamethylenetetramine.” Proc.